Prostate Cancer
Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.
August 25, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.
August 24, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
August 24, 2023
Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.
August 24, 2023
FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
August 23, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
August 22, 2023
Peri Prostatic Adipose Tissue (PPAT) MRI Radiomics Derived Features Associated with Clinically Significant Prostate Cancer.
August 22, 2023